Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dermatology
Positive results from initial pre-clinical testing of anti-aging drugs
February 3rd, 2005
Senetek PLC (SNTKY), a healthcare technologies company engaged in developing products for the anti-aging market, announced positive results from its initial multi-faceted study of the effects of an adenine derivative, Zeatin, and 2 other new compounds representing new cytokinin classifications, AK801 and PRK124. The study was conducted over a 3-week period at the Department of Dermatology, University of California at Irvine using the hairless mouse model. This study model is designed to evaluate new compounds for safety and efficacy in the potential treatment of skin anti-aging and to investigate the mechanisms by which they affect the skin aging...
Source: Women's Health Weekly (2005-02-03)
|
